Symbol: |
TCEANC2
|
Description: |
transcription elongation factor A (SII) N-terminal and central domain containing 2 [Source:HGNC Symbol;Acc:26494]
|
Location: |
Chr1:54519260-54578192[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:86
Gene |
Compound |
Gen_sig |
Exp_pattern |
TCEANC2 |
NSC 119621 |
0.004 |
Up |
TCEANC2 |
NSC 168197 |
0.049 |
Down |
TCEANC2 |
NSC 175296 |
0.045 |
Down |
TCEANC2 |
2-Imidazoline-1-ethanol, .alpha.,4,4-trimethyl-2-undecyl- |
0.02 |
Down |
TCEANC2 |
Methanaminium, N-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) |
0.006 |
Down |
TCEANC2 |
NSC 27413 |
0.014 |
Down |
TCEANC2 |
Trichopolyn |
0.007 |
Down |
TCEANC2 |
1-Piperazinecarboselenoic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide |
0.03 |
Down |
TCEANC2 |
CYTOVARICIN |
0.02 |
Down |
TCEANC2 |
5,5'-bis(2-methyl-1H-indol-3-yl)-3,3'-biisoxazole |
0.016 |
Down |
TCEANC2 |
ANTINEOPLASTIC-376265 |
0.011 |
Down |
TCEANC2 |
NSC 376354 |
0.046 |
Up |
TCEANC2 |
NSC 404886 |
0.031 |
Up |
TCEANC2 |
NSC 49692 |
0.019 |
Down |
TCEANC2 |
NSC 50567 |
0.001 |
Down |
Expression pattern: Sensitivity / Resistance
Total:6 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:43
Total:3 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|